From the Journals

A New Hub for Liver Research Tackles Its First Investigations

Mount Sinai's newly launched Institute for Liver Research has funded its first two pilot projects, chosen from among 11 applications submitted by basic, translational, or clinical research teams, and awarded one-year grants of $30,000 each in hopes of generating preliminary data sufficient to stimulate broader funding and research collaborations. One project focuses on genomics and genetic sequencing of patients to determine how many and which abnormalities are linked to liver disease, while the other proposes to develop a lipid nanoparticle platform for hepatic stellate cell-specific drug delivery.

  • by

  • October 2, 2025

  • 1 min

Share

6 Key Takeaways

  • 1

    Mount Sinai's Institute for Liver Research launches funding.

  • 2

    Two pilot projects receive $30,000 each.

  • 3

    Focus on genomics to identify liver disease abnormalities.

  • 4

    Development of lipid nanoparticle drug delivery system.

  • 5

    Total of 11 applications submitted for funding.

  • 6

    Aims to generate preliminary data for additional research collaborations.

Related Content

Gastric microbiome shifts track H pylori virulence

Pathogenic bacterial genotypes correlate with distinct microbial communities; overall α-diversity is unchanged, but virulent strains show greater diversity within subgroups as atrophy progresses

Exercise Patterns and GI Cancer Risk

Consistently meeting—but not exceeding—recommended activity levels offers maximal protection against digestive cancers, new research suggests.

Sarcopenia, thrombosis, and renal dysfunction dominate cirrhosis complication updates

New diagnostic approaches and treatment controversies emerge for managing advanced liver disease complications.